First-pass extracted concept

hepatic lifecycle of AAV

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

These key steps start after vector infusion, including receptor engagement, cellular uptake, endosomal escape, nuclear entry, and transgene expression.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1performance determinantsupports2025Source 1DOI PubMed

The stages of the AAV hepatic lifecycle can influence transduction efficiency and contribute to differences in treatment outcomes between individuals.

Claim 2process dependencysupports2025Source 1DOI PubMed

Receptor engagement, cellular uptake, endosomal escape, nuclear entry, and transgene expression are key post-infusion stages in the hepatic lifecycle of AAV.

Claim 3safety and durabilitysupports2025Source 1DOI PubMed

How AAV persists in cells may inform long-term efficacy and safety.